GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » eFFECTOR Therapeutics Inc (FRA:LWK) » Definitions » YoY EPS Growth

eFFECTOR Therapeutics (FRA:LWK) YoY EPS Growth : 64.31% (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is eFFECTOR Therapeutics YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. eFFECTOR Therapeutics's YoY EPS Growth for the quarter that ended in Mar. 2024 was 64.31%.

eFFECTOR Therapeutics's Earnings per Share (Diluted) for the three months ended in Mar. 2024 was €-1.99.

eFFECTOR Therapeutics YoY EPS Growth Historical Data

The historical data trend for eFFECTOR Therapeutics's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

eFFECTOR Therapeutics YoY EPS Growth Chart

eFFECTOR Therapeutics Annual Data
Trend Dec20 Dec21 Dec22 Dec23
YoY EPS Growth
- 11,352.94 -233.43 -15.57

eFFECTOR Therapeutics Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -450.35 2.44 47.57 39.60 64.31

eFFECTOR Therapeutics YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

eFFECTOR Therapeutics's YoY EPS Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY EPS Growth (A: Dec. 2023 )
=(Earnings per Share (Diluted) (A: Dec. 2023 )-Earnings per Share (Diluted) (A: Dec. 2022 ))/ | Earnings per Share (Diluted) (A: Dec. 2022 ) |
=(-15.011--12.989)/ | -12.989 |
=-15.57 %

eFFECTOR Therapeutics's YoY EPS Growth for the quarter that ended in Mar. 2024 is calculated as:

YoY EPS Growth (Q: Mar. 2024 )
=(Earnings per Share (Diluted) (Q: Mar. 2024 )-Earnings per Share (Diluted) (Q: Mar. 2023 )) / | Earnings per Share (Diluted) (Q: Mar. 2023 )) |
=(-1.987--5.567)/ | -5.567 |
=64.31 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

eFFECTOR Therapeutics YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of eFFECTOR Therapeutics's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

eFFECTOR Therapeutics (FRA:LWK) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » eFFECTOR Therapeutics Inc (FRA:LWK) » Definitions » YoY EPS Growth
Comparable Companies
CGTX VTVT PVCT PMN ELDN NERV INKT COEP PASG HOOK OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
EFTR:USA LWK:Germany
Address
142 North Cedros Avenue, Suite B, Solana Beach, CA, USA, 92075
Website
https://www.effector.com
eFFECTOR Therapeutics Inc is a clinical-stage biopharmaceutical company focused on pioneering the development of a new class of oncology drugs referred to as selective translation regulator inhibitors (STRIs).

eFFECTOR Therapeutics (FRA:LWK) Headlines

No Headlines